Next Article in Journal
MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer
Next Article in Special Issue
Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
Previous Article in Journal
Loss of CENP-I Impairs Homologous Recombination and Sensitizes Cells to PARP1 Inhibition
Previous Article in Special Issue
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using 18F-FDG PET/CT, EZRIN, and KI67
 
 
Article

Article Versions Notes

Cancers 2021, 13(13), 3201; https://doi.org/10.3390/cancers13133201
Action Date Notes Link
article pdf uploaded. 26 June 2021 15:08 CEST Version of Record https://www.mdpi.com/2072-6694/13/13/3201/pdf-vor
article xml file uploaded 29 June 2021 04:12 CEST Original file -
article xml uploaded. 29 June 2021 04:12 CEST Update -
article pdf uploaded. 29 June 2021 04:12 CEST Updated version of record https://www.mdpi.com/2072-6694/13/13/3201/pdf-vor
article supplementary file uploaded. 29 June 2021 04:12 CEST - https://www.mdpi.com/2072-6694/13/13/3201#supplementary
article html file updated 29 June 2021 04:13 CEST Original file -
article html file updated 29 June 2021 04:18 CEST Update -
article xml file uploaded 6 July 2021 09:15 CEST Update -
article xml uploaded. 6 July 2021 09:15 CEST Update https://www.mdpi.com/2072-6694/13/13/3201/xml
article pdf uploaded. 6 July 2021 09:15 CEST Updated version of record https://www.mdpi.com/2072-6694/13/13/3201/pdf
article html file updated 6 July 2021 09:17 CEST Update -
article html file updated 6 July 2021 09:24 CEST Update -
article html file updated 27 July 2022 02:10 CEST Update https://www.mdpi.com/2072-6694/13/13/3201/html
Back to TopTop